#targetedtherapy — Public Fediverse posts

GSK, Hansoh Lung Cancer Drug Hits Main Survival Goal in China Trial

British drugmaker GSK and its Chinese partner Hansoh Pharmaceutical have reported that their targeted cancer therapy, known as…
#EuropeSays #Britain #Europe #EU #GSK #antibodydrugconjugate #cancertreatmentinnovation #Chinaclinicaltrial #globaloncologypipeline #HansohPharmaceutical #Oncology #overallsurvival #Phase3trial #progression-freesurvival #ris-rez #smallcelllungcancer #targetedtherapy
https://www.europesays.com/britain/81834/

https://www.europesays.com/britain/81834/ GSK, Hansoh Lung Cancer Drug Hits Main Survival Goal in China Trial #AntibodyDrugConjugate #CancerTreatmentInnovation #ChinaClinicalTrial #GlobalOncologyPipeline #GSK #HansohPharmaceutical #Oncology #OverallSurvival #Phase3Trial #ProgressionFreeSurvival #RisRez #SmallCellLungCancer #TargetedTherapy

https://www.europesays.com/ch/85457/ FDA Approves Roche PTEN Assay for Prostate Cancer Protein Deficiency #CancerTesting #ClinicalDiagnostics #CompanionDiagnostics #FDAApproval #immunohistochemistry #LaboratoryAssays #ProstateCancer #ProteinBiomarkers #PTENDeficiency #Roche #TargetedTherapy #TRUQAP

https://www.europesays.com/ch/65358/ How This Former Army Officer Helps Deliver Cancer Treatments to Patients, Through Hurricanes and Beyond #Careers #CellTherapy #EmergingTechnology #GeneTherapy #GlobalHealthcareCompanies #InnovativeHealthcare #InnovativeMedicines #Novartis #NovartisOncologyPipeline #NovartisPharmaceuticals #Oncology #OncologyDrugDevelopment #RareDiseasePatients #RareDiseaseTreatment #sandoz #SandozPharmaceuticals #TargetedTherapy #WorkingAtNovartis

https://www.europesays.com/ch/57123/ Novartis Adds New Therapies As Shares Trade Below Analyst Value Targets #ChronicSpontaneousUrticaria #EuropeanCommission #Novartis #SharePrice #TargetedTherapy #WorldHealthOrganization

https://www.europesays.com/ch/56236/ Novartis Rhapsido® receives European Commission approval #ChronicIllness #Innovation #MediaRelease #Novartis #NovartisPharmaAG #ReimagineMedicine #SwissStockExchange:NOVNSW #TargetedTherapy

Novartis Rhapsido® receives European Commission approval

Significant improvements as early as Week 1, favorable safety profile and no liver safety concerns in REMIX 1 & 2 studies of highly…
#Europe #EU #EuropeanCommission #ChronicIllness #innovation #mediarelease #NovartisPharmaAG #ReimagineMedicine #SwissStockExchange:NOVN.SW #TargetedTherapy
https://www.europesays.com/europe/23661/

https://www.europesays.com/be/10441/ Radioligand Therapy Set to Transform Oncology Care #Belgium #BiologicTherapy;Biologics #cancer #CancerCareReimbursement #carcinoma #Innovation #InnovationsInMedicine #MalignantNeoplasia #MalignantNeoplasm #MedicalInnovations #NuclearMedicine #OncologyReimbursement #ProstateCarcinoma;MalignantProstateNeoplasm;ProstateCancer;CancerOfTheProstate #ReimbursementInOncology #TargetedCancerTherapy #TargetedTherapy

https://www.europesays.com/ch/35606/ Novartis Expands Cancer Drug Portfolio with $3 Billion Acquisition #BreastCancer #CancerTherapy #CancerTreatment #DrugAcquisition #Novartis #PharmaceuticalDeal #PI3KαInhibitors #SNV4818 #SynnovationTherapeutics #TargetedTherapy

https://www.europesays.com/ch/35593/ Novartis to buy experimental breast cancer drug in up to $3 billion deal #BreastCancer #cancer #CancerDrugs #ExperimentalDrug #Novartis #TargetedTherapy

🎯 HCC treatment is evolving…
TACE + immunotherapy + targeted therapy shows stronger outcomes—but are we ready to change practice?

⚠️ Promising data, but guidelines still need phase III confirmation

#GastroAGI #HCC #LiverCancer #TACE #Immunotherapy #TargetedTherapy #Hepatology #Oncology #MedEd

🎯 HCC treatment is evolving…
TACE + immunotherapy + targeted therapy shows stronger outcomes—but are we ready to change practice?

⚠️ Promising data, but guidelines still need phase III confirmation

#GastroAGI #HCC #LiverCancer #TACE #Immunotherapy #TargetedTherapy #Hepatology #Oncology #MedEd

🎯 HCC treatment is evolving…
TACE + immunotherapy + targeted therapy shows stronger outcomes—but are we ready to change practice?

⚠️ Promising data, but guidelines still need phase III confirmation

#GastroAGI #HCC #LiverCancer #TACE #Immunotherapy #TargetedTherapy #Hepatology #Oncology #MedEd

🎯 HCC treatment is evolving…
TACE + immunotherapy + targeted therapy shows stronger outcomes—but are we ready to change practice?

⚠️ Promising data, but guidelines still need phase III confirmation

#GastroAGI #HCC #LiverCancer #TACE #Immunotherapy #TargetedTherapy #Hepatology #Oncology #MedEd

https://www.europesays.com/ch/30720/ 25 Year Anniversary of Innovation in Treating CML #advancements #advocacy #BloodCancer #chronic #ChronicMyeloidLeukemia #ClinicalAdvancements #CML #Cultural #HealthCare #hematology #Innovation #leukemia #Novartis #Oncology #patients #research #TargetedTherapy #technological #TKI #TyrosineKinaseInhibitor

Nhà khoa học trẻ TP.HCM phát triển vật liệu nano dẫn truyền thuốc trúng đích, hứa hẹn mở ra hướng mới trong điều trị ung thư. #nanotechnology #cancerresearch #TPHCM #khoahọc #y học #đột phá

#materials #science #research #oncology #innovation #Vietnam #HCMC #nanomaterials #drugdelivery #targetedtherapy

https://vtcnews.vn/nha-khoa-hoc-tre-tp-hcm-tao-vat-lieu-nano-huong-toi-dieu-tri-ung-thu-ar995149.html

Nhà khoa học trẻ TP.HCM phát triển vật liệu nano dẫn truyền thuốc trúng đích, hứa hẹn mở ra hướng mới trong điều trị ung thư. #nanotechnology #cancerresearch #TPHCM #khoahọc #y học #đột phá

#materials #science #research #oncology #innovation #Vietnam #HCMC #nanomaterials #drugdelivery #targetedtherapy

https://vtcnews.vn/nha-khoa-hoc-tre-tp-hcm-tao-vat-lieu-nano-huong-toi-dieu-tri-ung-thu-ar995149.html

WTOP’s Neal Augenstein: 3 years after Stage 4 lung cancer diagnosis, what’s next

During the first three years of Augenstein’s lung cancer journey, he’s been happy to be able to share…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Health #aminbenyounes #Clinicaltrials #inovaschar #LungCancer #targetedtherapy
https://www.newsbeep.com/us/307918/

WTOP’s Neal Augenstein: 3 years after Stage 4 lung cancer diagnosis, what’s next

During the first three years of Augenstein’s lung cancer journey, he’s been happy to be able to share…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Health #aminbenyounes #Clinicaltrials #inovaschar #LungCancer #targetedtherapy
https://www.newsbeep.com/us/307918/

Chemotherapy may soon take a backseat. Experts say targeted therapies—drugs that attack cancer at the genetic level—are transforming breast cancer treatment. https://english.mathrubhumi.com/lifestyle/health/targeted-breast-cancer-therapies-personalized-treatment-jbuout1i?utm_source=dlvr.it&utm_medium=mastodon #BreastCancerAwareness #TargetedTherapy #PrecisionOncology

Chemotherapy may soon take a backseat. Experts say targeted therapies—drugs that attack cancer at the genetic level—are transforming breast cancer treatment. https://english.mathrubhumi.com/lifestyle/health/targeted-breast-cancer-therapies-personalized-treatment-jbuout1i?utm_source=dlvr.it&utm_medium=mastodon #BreastCancerAwareness #TargetedTherapy #PrecisionOncology

Chemotherapy may soon take a backseat. Experts say targeted therapies—drugs that attack cancer at the genetic level—are transforming breast cancer treatment. https://english.mathrubhumi.com/lifestyle/health/targeted-breast-cancer-therapies-personalized-treatment-jbuout1i?utm_source=dlvr.it&utm_medium=mastodon #BreastCancerAwareness #TargetedTherapy #PrecisionOncology

https://www.europesays.com/ie/144198/ Tiny metal particles show potential in targeting cancer cells: Study #CancerResearch #Éire #Health #IE #Ireland #MedicalInnovation #Nanotechnology #RMITUniversity #TargetedTherapy

Breakthrough study identifies effective treatment sequence for aggressive blood cancers, improving patient survival rates. #BloodCancer #OncologyResearch #TargetedTherapy

https://geekoo.news/targeted-therapies-transform-blood-cancer-treatment/

I am excited to see this paper coming up. Signals of activity noted with mono therapy and combination with cetuximab #KRAS #G12C #ColorectalCancer #TargetedTherapy #adagrasib

https://www.nejm.org/doi/full/10.1056/NEJMoa2212419#

I am excited to see this paper coming up. Signals of activity noted with mono therapy and combination with cetuximab #KRAS #G12C #ColorectalCancer #TargetedTherapy #adagrasib

https://www.nejm.org/doi/full/10.1056/NEJMoa2212419#

#multiplemyeloma #immunotherapy #targetedtherapy #ash22 #ash2022

#multiplemyeloma #immunotherapy #targetedtherapy #ash22 #ash2022